Gene Query: NOCT

Dataset Description Geneva Score
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 98.27
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 77.99
Gene expression in PANC1 cells treated with Rakicidin 74.73
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 69.01
Glioblastoma stem cells infected by ZIKA virus 55.87
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 55.8
Effect of ILF3 on translation during homeostasis and the antiviral response 48.63
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 48.23
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 43.79
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 41.59
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 39.16
A role for ZNF598 in post-transcriptional gene regulation 37.7
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 31.3
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 30.91
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 30.29
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 21.54
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 21.54
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 21.39
LncRNA-GAS5 negative regulation of YAP-target genes expression 20.97
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 19.83
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 18.9
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 18.84
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 18.65
RNA-seq of YB5 cells treated with Proscillaridin A 18.53
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 18.48
Primary human trophoblast from term placenta 18.02
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 17.98
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 17.92
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 17.65
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 17.54
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 17.4
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 17.31
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 17.01
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 16.84
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 16.33
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 15.88
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 15.7
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 15.47
ADAR1-editing of cellular and measles virus-derived duplex RNA 15.47
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 15.04
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 14.37
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 14.37
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 14.15
Ebola virus (EBOV) infection of ARPE-19 cells 13.77
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 13.4
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 13.05
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 12.95
DRB/GRO-Seq -/+ UV 12.87
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 12.49
Noncoding regions are the main source of targetable tumor-specific antigens 12.43
RNAseq Analysis in glioblastoma cells treated with Mepazine 12.05
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 11.75
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 11.2
Genome-wide analysis of Dengue virus 2 infected cells 11.1
A549 cell transcriptome responses to infection with H7N9 influenza virus 10.49
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 10.37
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 10.37
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 9.69
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 9.69
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 9.65
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 9.57
RNA-Seq from early time points in the kidney differentiation protocol 9.38
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 9.16
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 9.02
Argonaute proteins couple chromatin silencing to alternative splicing 9.02
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 8.98
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 8.98
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 8.87
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 8.76
Effect of Influenza virus infection on lncRNA expression in A549 cells 8.74
A sister of NANOG regulates genes expressed in pre-implantation human development 8.6
Role of COP1 on MAP kinase transcriptional output in melanoma 8.59
NAPRT activation of macrophages 8.56
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 8.53
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 8.24
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 8.21
Transcriptome analysis in Neobractatin treated cells 8.04
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 7.97
Oncogenic MYC induces a dependency on the spliceosome in human cancer 7.94
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 7.92
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 7.88
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 7.88
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 7.83
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 7.75
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 7.58
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 7.38
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 7.34
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 7.02
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 7.02
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 6.98
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 6.93
Mitochondrial dsRNA triggers antiviral signalling in humans 6.77
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 6.76
4sU-seq of HFF exposed to salt and heat stress 6.57
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 6.52
Nrf2 regulated genes in A549 cells 6.52
Identification of Nrf2 regulated genes by RNA sequencing 6.52
Chromatin-informed inference of transcriptional programs in gynecologic cancers 6.5
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 6.5
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 6.47
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 6.42
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 6.23
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 6.2
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 6.2
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 6.15
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 6.15
Irf9 function in immunity in mouse 6.15
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 6.12
BAF controls genome accessibility 6.0
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 5.98
Selective suppression of endothelial cytokine production by progesterone receptor 5.98
mRNA-sequencing of breast cancer subtypes and normal tissue 5.94
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 5.93
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 5.88
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 5.81
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 5.81
The bromodomain protein BRD4 regulates splicing during heat shock 5.74
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 5.7
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 5.56
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 5.4
Role of microRNAs in the interaction between Salmonella and the host cell 5.3
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  5.2
Real-time observation of light-controlled transcription in living cells 5.14
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 5.13
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 5.1
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 5.06
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 5.06
snRNAs as regulators of alternative splicing 5.03
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 4.86
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 4.85
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 4.84
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 4.74
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 4.7
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 4.7
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 4.66
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 4.6
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 4.59
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 4.52
Intrahepatic MAIT cell gene expression revealed by RNA-seq 4.47
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 4.46
Depicting early human development and germ cell origin with porcine embryos 4.45
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 4.38
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 4.3
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 4.3
RNAseq analysis of ESRP regulated splicing events in prostate cancer 4.25
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 4.22
CD95/Fas ligand mRNA is toxic to cells 4.2
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 4.15
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 4.14
Transcriptome analysis of kidney organoids 4.11
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 4.02
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 4.02
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 3.98
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 3.98
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 3.97
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 3.96
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 3.9
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 3.85
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 3.85
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 3.84
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.82
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 3.82
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 3.82
Gene expression analysis of dengue-infected cells 3.81
Transcriptomic analyssis following EHMT1/2 inhibition 3.7
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 3.7
FBXW7 modulates stress response by post-translational modification of HSF1 3.7
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 3.68
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 3.65
Dynamic reorganization of nuclear architecture during human cardiogenesis 3.63
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 3.63
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 3.6
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 3.58
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 3.55
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 3.55
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 3.54
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 3.54
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 3.54
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 3.52
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 3.51
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 3.51
Transcriptome analysis of virus infected tissues 3.49
RNA-seq of naive and primed ES cells 3.48
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 3.45
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 3.45
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 3.41
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 3.38
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 3.34
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 3.34
Transcriptomes of oxLDL exposed trained monocytes 3.33
oxLDL exposed trained monocytes 3.33
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 3.33
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 3.29
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 3.27
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 3.26
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 3.25
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 3.21
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 3.18
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 3.18
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 3.13
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 3.13
Reprogrammed myeloid cell transcriptomes in NSCLC 3.13
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 3.13
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 3.13
Landscape and variation of RNA secondary structure across the human transcriptome 3.1
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 3.09
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 3.06
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 3.06
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 3.06
U1 snRNP telescripting regulates size-function stratified human genome 3.06
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.03
TOP2B disturbed the quality of human oocytes with advanced maternal age 3.02
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 3.01
T47D RNA-seq and ChrRNA-seq data 3.0
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 3.0
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 2.99
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 2.99
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 2.95
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 2.94
Transcriptomic profiling of human peripheral blood-derived mast cells 2.87
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 2.87
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 2.85
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 2.85
Dermal endothelial cells of type 2 diabetic patients 2.82
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 2.81
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 2.8
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 2.8
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 2.79
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 2.79
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 2.77
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 2.75
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 2.75
Intron retention induced by microsatellite expansions as a disease biomarker. 2.75
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 2.73
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 2.73
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 2.73
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 2.72
Splicing and epigenetic factors jointly regulate epidermal differentiation 2.71
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 2.7
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 2.68
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 2.68
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 2.68
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 2.68
UV_24h_GRO-Seq 2.66
RIG-I and MDA5 fRIP during KSHV lytic reactivation 2.65
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 2.63
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 2.62
p53 activity results in DNA replication fork processivity 2.62
Capturing the Interactome of Newly Transcribed RNA 2.62
Capturing the Interactome of Newly Transcribed RNA (RICK) 2.62
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 2.61
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 2.59
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 2.57
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 2.56
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 2.56
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 2.56
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 2.56
RNA-seq analysis of BAP1-depleted uveal melanoma cells 2.55
Sensing self and nonself circular RNAs 2.55
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 2.55
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 2.54
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 2.54
The landscape of alternative splicing in aggressive prostate cancers 2.45
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 2.44
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 2.44
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 2.43
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 2.42
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 2.4
Silencing SPIB in attached and floating state of H1703 lung cancer cells 2.38
CD73 knockdown effect in pancreatic cancer cell lines 2.38
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 2.37
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 2.35
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 2.35
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 2.35
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 2.34
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 2.33
Effect of BB608 on Gene Expression in HNSCC Cell Line 2.32
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 2.3
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 2.29
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 2.25
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 2.25
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 2.25
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 2.24
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 2.23
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 2.23
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 2.23
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 2.23
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 2.23
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 2.23
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 2.22
Genome-wide Analysis of Chromatin Interactions in Human Cells 2.22
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 2.21
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 2.2
DIGIT regulates endoderm differentiation of human embryonic stem cells 2.2
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 2.2
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 2.2
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 2.2
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 2.19
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 2.15
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 2.14
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 2.13
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 2.13
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 2.12
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 2.11
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 2.09
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 2.09
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 2.07
SNHG5 siRNA knock down in HCT116 cells 2.07
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 2.07
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 2.05
RNA-seq of RKO cells with cTAZ KO or putback 2.03
RNA-sequencing of human tendon after injury 2.03
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 2.03
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 2.01
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 1.98
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 1.98
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 1.97
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.95
The pioneer factor CEBPA modulates vitamin D signaling 1.95
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 1.95
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 1.94
High-throughput sequencing of pluripotent cells 1.92
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 1.88
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 1.87
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.85
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.84
Exploring ILF2 regulatory genes by next-generation sequencing 1.83
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 1.79
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.79
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 1.74
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 1.73
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 1.73
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 1.73
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 1.72
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.71
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.68
SRSF1 role in cellular gene expression and splicing 1.67
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 1.66
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.65
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 1.64
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 1.63
Effect of nuclear IL-33 on gene expression 1.62
CSL RNA-Seq on HKC and SCC cell lines 1.62
CSL 1.62
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 1.62
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 1.62
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 1.59
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 1.58
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 1.57
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 1.53
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 1.52
MicroRNA-125a-5p overexpression in human macrophages 1.5
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 1.5
RNA-Seq of the corpus callosum from 12 individuals 1.45
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 1.43
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 1.42
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 1.42
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.42
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 1.39
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 1.39
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 1.37
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 1.34
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 1.34
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 1.32
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 1.32
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 1.3
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 1.3
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 1.3
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 1.3
Integrin signaling regulates YAP/TAZ to control skin homeostasis 1.29
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 1.28
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 1.28
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 1.26
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.25
CircRNAome diversity in human mature B-cells, T-cells and monocytes 1.25
High-efficiency RNA-based reprogramming of human primary fibroblasts 1.23
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 1.22
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 1.21
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 1.19
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 1.18
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 1.17
TT-Seq captures the human transient transcriptome 1.17
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 1.16
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 1.16
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 1.15
Identification of long noncoding RNAs regulated by p53 1.14
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 1.13
Genome-wide chromatin analysis of Ewing sarcoma 1.13
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 1.13
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 1.13
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 1.1
Loss of CREBBP results in gene expression repression in lymphoma cells 1.1
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 1.1
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 1.08
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 1.07
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 1.05
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 1.05
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.04
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 1.03
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 1.03
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.03
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 1.02
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 1.01
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 1.01
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 1.0
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 1.0
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 0.97
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.96
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.95
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.95
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 0.94
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 0.94
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.92
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.92
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.91
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.9
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.9
p63 controls the enhancer landscape during keratinocyte differentiation 0.9
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.88
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 0.87
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 0.87
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 0.84
Transcriptomes of human monocytes after ex vivo exposure to uric acid 0.83
Transcriptional landscape changes during human embryonic stem cell derivation 0.81
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.81
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 0.79
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 0.79
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 0.79
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 0.79
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 0.78
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 0.72
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.71
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 0.7
Postnatal lipids drive hepatocyte maturation 0.7
Molecular Criteria for Defining the Naive Human Pluripotent State 0.7
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.68
AMPK signaling for naïve pluripotency [Hs] 0.68
AMPK signaling for naïve pluripotency 0.68
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 0.68
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.67
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.66
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.65
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.64
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 0.62
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.61
Epigenome regulation during epidermal lineage commitment [RNA-seq] 0.61
Cell responses to dysregulated VZV-induced cell-cell fusion 0.6
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 0.56
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.55
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 0.54
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.54
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 0.53
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 0.53
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 0.53
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 0.53
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 0.49
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.48
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 0.48
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 0.44
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.43
The effect of insulin on mRNA transcription of human pluripotent stem cells 0.43
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.42
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 0.4
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 0.4
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 0.39
RNA-seq of primary patient AML samples 0.37
Leucegene: AML sequencing (part 6) 0.37
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 0.37
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.36
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.36
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 0.34
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.32
Specific molecular signatures underlie response to decitabine in CMML 0.32
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.32
A single-cell transcriptome atlas of the human pancreas 0.32
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 0.29
Small-molecule targeting of brachyury transcription factor addiction in chordoma 0.28
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.24
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.22
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.22
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.19
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.17
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.16
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.16
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 0.14
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.14
Ribosome profiling upon inhibition of eIF4A 0.14
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 0.13
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.13
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 0.11
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 0.1
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 0.09
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.08
MHC Transcriptomic landscape at haplotype-specific resolution 0.07
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 0.05
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 0.03
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.01
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.01
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.01
Transcriptome analysis of peripheral blood monocytes 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation